Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.59 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.58 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.58 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.55 |
| ▸ | DRD2 | P14416 | 2/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.51 |
| ▸ | HRH1 | P35367 | 3/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | DRD4 | P21917 | 1/20 | 0.50 |
| ▸ | DRD5 | P21918 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20124587 | 0.91 | L3MBTL1 (0.55) | LTA4HSIGMAR1HRH3SLC6A3DRD2 | |
| SCHEMBL19043759 | 0.91 | LTA4H (0.51) | LTA4HSIGMAR1HRH3SLC6A3DRD2 | |
| SCHEMBL19043541 | 0.87 | HRH3 (0.80) | LTA4HSIGMAR1HRH3SLC6A3DRD2 | |
| SCHEMBL7983264 | 0.87 | CYP2D6 (0.57) | LTA4HSIGMAR1HRH3SLC6A3DRD2 | |
| SCHEMBL791288 | 0.85 | CYP2D6 (0.55) | LTA4HSIGMAR1HRH3DRD2HRH1 | |
| SCHEMBL7923985 | 0.82 | HRH3 (0.82) | SIGMAR1HRH3DRD2ALDH1A1 | |
| SCHEMBL18934284 | 0.82 | SIGMAR1 (0.51) | SIGMAR1HRH3 | |
| SCHEMBL7491557 | 0.81 | HRH3 (0.48) | LTA4HSIGMAR1HRH3HRH1 | |
| SCHEMBL5302082 | 0.81 | LTA4H (0.86) | LTA4HSIGMAR1HRH3SLC6A3GRIN2B | |
| SCHEMBL11337893 | 0.80 | SIGMAR1 (0.60) | LTA4HSIGMAR1HRH3SLC6A3HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108290749-A | Novel synthetic crystalline EMM-28 material, its preparation and use | 埃克森美孚研究工程公司 | 2018-07-17 | — | — | CN | claimed |
| CN-111491891-B | EMM-31 material, method and use thereof | 埃克森美孚科技工程公司 | 2023-07-04 | — | — | CN | disclosed |
| CN-108290749-B | Novel synthetic crystalline EMM-28 material, its preparation and use | 埃克森美孚科技工程公司 | 2022-06-24 | — | — | CN | disclosed |
| EP-3728119-A1 | EMM-31 MATERIALS AND PROCESSES AND USES THEREOF | ExxonMobil Research and Engineering Company (US) | 2020-10-28 | — | — | EP | disclosed |
| EP-3383796-B1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RES & ENG CO (US) | 2020-09-16 | — | — | EP | disclosed |
| US-10710889-B2 | EMM-31 materials and processes and uses thereof | EXXONMOBIL RESEARCH & ENGINEERING COMPANY (US) | 2020-07-14 | — | — | US | disclosed |
| US-10710889-B2 | EMM-31 materials and processes and uses thereof | EXXONMOBIL RESEARCH & ENGINEERING COMPANY (US) | 2020-07-14 | — | — | US | disclosed |
| US-20190218106-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RES & ENG CO (US) | 2019-07-18 | — | — | US | disclosed |
| US-20190194028-A1 | EMM-31 MATERIALS AND PROCESSES AND USES THEREOF | EXXONMOBIL RES & ENG CO (US) | 2019-06-27 | — | — | US | disclosed |
| US-20190194028-A1 | EMM-31 MATERIALS AND PROCESSES AND USES THEREOF | EXXONMOBIL RES & ENG CO (US) | 2019-06-27 | — | — | US | disclosed |
| US-10252918-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2019-04-09 | — | — | US | disclosed |
| CN-108290749-A | Novel synthetic crystalline EMM-28 material, its preparation and use | 埃克森美孚研究工程公司 | 2018-07-17 | — | — | CN | disclosed |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-08 | — | — | US | disclosed |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-08 | — | — | US | disclosed |
| WO-2017095705-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2017-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194028-A1 | EMM-31 MATERIALS AND PROCESSES AND USES THEREOF | CD14, MASP2, FGB | LTA4H 2193/4885SIGMAR1 4192/4885HRH3 2990/4885 |
| US-10252918-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | CD14, ERG28, DAP3 | LTA4H 3486/4885SIGMAR1 3782/4885HRH3 3023/4885 |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | CD14, ERG28, DAP3 | LTA4H 3486/4885SIGMAR1 3782/4885HRH3 3023/4885 |
| US-20190218106-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | CD14, ERG28, DAP3 | LTA4H 3486/4885SIGMAR1 3782/4885HRH3 3023/4885 |
| US-10710889-B2 | EMM-31 materials and processes and uses thereof | CD14, MASP2, FGB | LTA4H 2193/4885SIGMAR1 4192/4885HRH3 2990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.